skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Download Your Copy Now

Don't miss out on this comprehensive review of all the presentations from the conference, complied by our analysts, with key points and expert insight, for you to download, for free. A full list of events and catalysts that were announced or updated during the conference is included in this report.

Below are some of the key points from the conference’s presentations which are covered in detail in the full report:

  • Celgene (CELG) announced acquiring Impact Biomedicines and its late-stage myelofibrosis asset fedratinib
  • Regeneron Pharmaceuticals (REGN) announced the biggest news with an additional $1bn commitment from Regeneron and Sanofi towards cemiplimab
  • Pfizer highlighted H1 2018 milestones
  • Roche Holding’s (RHHBY) highlighted the company’s sixth consecutive year of sales growth
  • AbbVie (ABBV) focused on its flagship product, Humira
  • Spark Therapeutics (ONCE) announced a new gene therapy program
JP Morgan Healthcare Review 2018





電話:+81 (0)3 6273 4260